FeesSafety
Pluang+

Blue Moon Metals contracts refurbishment for Springer tungsten mill, targets restart in late 2027.

Company Fundamentals
26 Oct 2026, 23:53 WIB
PRNewsWire
View Source
Bullish
Blue Moon Metals contracts refurbishment for Springer tungsten mill, targets restart in late 2027.

Blue Moon Metals has contracted RAM Enterprise and Nordmin Engineering to refurbish the Springer tungsten processing plant in Nevada, aiming to complete by Q4 2027. Wood Group USA will oversee the project as Owner's Engineer. The company also acquired nearby accommodations for workers during construction. This project aims to restart domestic tungsten mining in the U.S., supporting national defense and local economic growth in Nevada.

Blue Moon Metals' refurbishment contract for the Springer tungsten plant is noted here alongside Pluang's Basic Materials sector market snapshot as of Oct 27, 2026 03:11 WIB: Out of 83 priced US stocks, 39 rose and 43 fell. Key movers include USA Rare Earth Inc. (USAR) at USD 8.95 with Pluang order activity showing 4% Sell / 96% Buy and a typical hold time of 5 days, Vale SA (VALE) at USD 11.93 with 6% Sell / 94% Buy and a 111-day hold time, and Ternium S.A. (TX) at USD 53.93 with a 12-day hold time. This snapshot provides a view of market activity in the sector during this period.

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
1 hour ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
1 hour ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
1 hour ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
3 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App